141 related articles for article (PubMed ID: 21909502)
1. Correlation of serum levels of vascular endothelial growth factor with TNM staging, histopathologic grading, and surgical therapy for oral squamous cell carcinoma.
Jaiswal SG; Gadbail AR; Chaudhary MS; Jaiswal GR; Gawande M
Quintessence Int; 2011 Oct; 42(9):771-9. PubMed ID: 21909502
[TBL] [Abstract][Full Text] [Related]
2. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of hepatocyte growth factor (HGF) in oral squamous cell carcinoma before and after surgery. Preliminary report.
Borgiel-Marek H; Kajdaniuk D; Niedzielska I; Kos-Kudła B; Tarabura-Dragon J; Marek B
Endokrynol Pol; 2008; 59(6):467-70. PubMed ID: 19347810
[TBL] [Abstract][Full Text] [Related]
5. [Markers in patients with squamous cell carcinoma of the oral cavity. Expression and long-term follow-up of VEGF, FLT-1 and Tie2 in serum].
Schimming R; Gellrich NC; Eyrich G
HNO; 2004 Mar; 52(3):235-41. PubMed ID: 15007517
[TBL] [Abstract][Full Text] [Related]
6. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) in sera of oral and oropharyngeal squamous cell carcinoma patients.
Friedrich RE; Klapdor R; Hagel C; Bartel-Friedrich S
Anticancer Res; 2010 May; 30(5):1765-6. PubMed ID: 20592375
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck.
Khademi B; Soleimanpour M; Ghaderi A; Mohammadianpanah M
Oral Maxillofac Surg; 2014 Jun; 18(2):187-96. PubMed ID: 23456015
[TBL] [Abstract][Full Text] [Related]
9. [Research on the correlation of vascular endothelial growth factor and dendritic cell in patients with oral squamous cell carcinoma].
Shi PH; Hu QG; Wang ZY; Huang XF; Han W
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Mar; 44(3):135-9. PubMed ID: 19576015
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.
Andisheh-Tadbir A; Khademi B; Kamali F; Fattahi MJ; Malekzadeh M; Taghva M
Tumour Biol; 2014 Jun; 35(6):5689-93. PubMed ID: 24577893
[TBL] [Abstract][Full Text] [Related]
11. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation.
Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU
Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326
[TBL] [Abstract][Full Text] [Related]
12. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma.
Uehara M; Sano K; Ikeda H; Sekine J; Irie A; Yokota T; Tobita T; Ohba S; Inokuchi T
Oral Oncol; 2004 Mar; 40(3):321-5. PubMed ID: 14747064
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of preoperative serum epidermal growth factor levels in patients with oral squamous cell carcinoma.
Lin JS; Sun FJ; Lin PY; Chang KW; Yang CC; Liu CJ
Int J Oral Maxillofac Surg; 2018 Oct; 47(10):1236-1242. PubMed ID: 29843953
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunohistochemical expression of vascular endothelial growth factor and CD105 in oral squamous cell carcinoma: Its correlation with prognosis.
Patil BR; Bhat K; Somannavar P; Hosmani J; Kotrashetti V; Nayak R
J Cancer Res Ther; 2018; 14(2):421-427. PubMed ID: 29516931
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood dendritic cells and vascular endothelial growth factor in oral squamous cell carcinoma: correlation analysis and in vitro study.
Wang ZY; Shi PH; Huang XF; Hua ZC; Hou YY; Han W; Hu QG
Int J Oral Maxillofac Surg; 2010 Jul; 39(7):713-20. PubMed ID: 20395112
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma.
Lotfi A; Mohammadi G; Tavassoli A; Mousaviagdas M; Chavoshi H; Saniee L
Asian Pac J Cancer Prev; 2015; 16(4):1327-30. PubMed ID: 25743793
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.
Shang ZJ; Li JR; Li ZB
J Oral Maxillofac Surg; 2007 Jan; 65(1):17-21. PubMed ID: 17174758
[TBL] [Abstract][Full Text] [Related]
20. Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.
Ding L; Hu EL; Xu YJ; Huang XF; Zhang DY; Li B; Hu QG; Ni YH; Hou YY
Tumour Biol; 2015 Apr; 36(4):2523-9. PubMed ID: 25613064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
